Biotech stocks are tracking for their best quarter ever — here's how to play it

Biotech stocks took a tumble on Monday with the XBI S&P biotech ETF and IBB Nasdaq biotech ETF each falling by more than 1 percent.

"If you're playing biotech, you're counting on little companies doing something amazing and hopefully getting bought by a big company," Nadig said on CNBC's"ETF Edge" on Monday."We saw that in the last couple of weeks when Spark Therapeutics got bought by Roche, that was a significant position in XBI. It's barely in IBB."

To Ben Johnson, director of global ETF research at Morningstar, the equal-weighted XBI ETF offers big returns, but volatility in the biotech segment means investors need to have a strong stomach.

Switzerland Neuesten Nachrichten, Switzerland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Watch now: ETF Edge on the market sell-off, and the Tesla-heavy ETF that's beating the S&P this year
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »

Biotech stocks are going wild, and these two could be your best bet for a bigger breakoutBiotech is blazing higher. One technician says it should continue to be a healthy trade.
Herkunft: CNBC - 🏆 12. / 72 Weiterlesen »